[Intensification in vivo of free radical oxidation of low density lipoproteins in plasma from patients with myocardial ischemia treated by HMG-CoA-reductase pravastatin and suppression of lipid peroxidation by ubiquinone Q10].
Lankin
V Z
VZ
Tikhaze
A K
AK
Kaminnaia
V I
VI
Kaminnyĭ
A I
AI
Konovalova
G G
GG
Kukharchuk
V V
VV
D000975:Antioxidants / Q000627:therapeutic use*; D003067:Coenzymes; D004311:Double-Blind Method; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015227:Lipid Peroxidation / Q000187:drug effects*; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood*; D017035:Pravastatin / Q000627:therapeutic use*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000975:Antioxidants; D003067:Coenzymes; D005609:Free Radicals; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D014451:Ubiquinone; C024989:coenzyme Q10; D017035:Pravastatin